Quimiotipo CBD

Cannabis Strain by CBD Crew

Introduction
Quimiotipo CBD from CBD Crew represents the collaboration between Mr. Nice Seedbank's Shantibaba and Resin Seeds' Jaime, formed in 2009 to develop high-CBD, low-THC cannabis genetics for medical applications. The Spanish "Quimiotipo" (chemotype) designation emphasizes the strain's cannabinoid profile over recreational characteristics—a scientific approach to cannabis breeding focused on therapeutic potential.

Lineage
CBD Crew emerged when Shantibaba and Jaime tested CBD content in Cannabis from various sources and realized consistent high-CBD genetics remained rare in the seed market. Most breeding had selected for maximum THC, inadvertently reducing CBD levels across commercial genetics. Their collaboration aimed to reverse this trend, creating strains with CBD:THC ratios suitable for patients seeking therapeutic effects without intense psychoactivity.

Terpenes
Terpene profiles in CBD-focused strains often receive less documentation than THC varieties, though they contribute significantly to therapeutic effects through entourage interactions. Quimiotipo CBD likely expresses myrcene, beta-caryophyllene, and pinene—producing earthy, spicy, herbal aromatics rather than fruity or dessert profiles common in recreational breeding.

Growth
Cultivation characteristics for CBD Crew genetics typically emphasize stability, vigor, and reasonable yields—making medical cultivation commercially viable. Without specific flowering time data, growers should expect moderate timelines typical of worked hybrid genetics.

Effects
Effects focus on CBD's documented therapeutic properties: potential anti-inflammatory, anxiolytic, and anti-seizure effects without significant psychoactive experience. Specific CBD:THC ratios determine whether users experience any psychoactivity or purely therapeutic effects.

Documentation
CBD Crew continued operating through the 2010s, with their genetics influencing the broader medical cannabis movement toward balanced cannabinoid profiles.

⚠️ This information is for educational purposes only and should not be considered medical advice.

Sources: http://www.cbdcrew.org/